JPH06165696A - Indicator for measuring peroxide decomposing substance and reagent kit - Google Patents

Indicator for measuring peroxide decomposing substance and reagent kit

Info

Publication number
JPH06165696A
JPH06165696A JP14361792A JP14361792A JPH06165696A JP H06165696 A JPH06165696 A JP H06165696A JP 14361792 A JP14361792 A JP 14361792A JP 14361792 A JP14361792 A JP 14361792A JP H06165696 A JPH06165696 A JP H06165696A
Authority
JP
Japan
Prior art keywords
indicator
peroxide
substance
ratio
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP14361792A
Other languages
Japanese (ja)
Other versions
JPH07121235B2 (en
Inventor
Kunio Kawakatsu
邦夫 川勝
Yoshiyuki Amano
善之 天野
Ayumi Obara
歩美 小原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanyo Chemical Industries Ltd
Original Assignee
Sanyo Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanyo Chemical Industries Ltd filed Critical Sanyo Chemical Industries Ltd
Priority to JP4143617A priority Critical patent/JPH07121235B2/en
Publication of JPH06165696A publication Critical patent/JPH06165696A/en
Publication of JPH07121235B2 publication Critical patent/JPH07121235B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PURPOSE:To improve performances of an indicator for measuring a substance decomposable with a peroxide, comprising a peroxide and a benzidine-based color coupler. CONSTITUTION:A buffer solution as a medium is mixed with a peroxide, a benzidine-based color coupler and gamma-cyclodextrin and the benzidine-based color coupler is dissolved to give an indicator for measuring a substance decomposable with a peroxide.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、酵素免疫測定法等の分
野に利用され、ペルオキシダーゼなどの過酸化物分解性
物質を測定する目的で使用される、ベンジジン系発色剤
含有指示薬及びこの指示薬を含む試薬キットに関する。
FIELD OF THE INVENTION The present invention relates to an indicator containing a benzidine color-developing agent and this indicator, which is used in the field of enzyme immunoassay and the like and is used for the purpose of measuring a peroxide decomposable substance such as peroxidase. A reagent kit including the same.

【0002】[0002]

【従来の技術】酵素免疫測定法、生化学測定法等の分野
においては、水性媒体中に過酸化水素などの過酸化物お
よびベンジジン系発色剤を溶解させた指示薬が知られて
いる。この指示薬は、過酸化物分解性物質やこの物質で
標識された化合物等を測定対象として使用するものであ
り、この過酸化物分解性物質の測定を、この物質と過酸
化物との反応に伴うベンジジン系発色剤の発色により行
うものである。
2. Description of the Related Art In the fields of enzyme immunoassays, biochemical assays and the like, indicators in which a peroxide such as hydrogen peroxide and a benzidine type color former are dissolved in an aqueous medium are known. This indicator uses a peroxide decomposable substance or a compound labeled with this substance as a measurement target, and the measurement of this peroxide decomposable substance is performed in the reaction between this substance and peroxide. This is performed by color development of the accompanying benzidine-based color developing agent.

【0003】この指示薬に用いられるベンジジン系発色
剤は、以前より用いられているオルトフェニレンジアミ
ン等の発色剤と異なり、低毒性のものが多く、高感度で
あるという利点があるが、水にはわずかしか溶解しな
い。そのため、メタノール、1−メチル−2−ピロリド
ン等の有機溶剤を含む水溶液に、ベンジジン系発色剤を
高濃度溶解させ、使用前に緩衝液等で適当な濃度に希釈
して使用されていた(例えば、特開昭63−19927
0、特開昭62−500882、特開昭59−1668
65、特開昭49−133092号公報)。
Unlike the color formers such as ortho-phenylenediamine, which have been used for a long time, the benzidine-based color formers used for this indicator have many advantages of low toxicity and high sensitivity, but they are not suitable for water. Only slightly soluble. Therefore, methanol, an aqueous solution containing an organic solvent such as 1-methyl-2-pyrrolidone, a benzidine-based color developing agent is dissolved at a high concentration, and diluted with a buffer solution or the like to an appropriate concentration before use (for example, JP-A-63-19927
0, JP-A-62-500882, JP-A-59-1668
65, JP-A-49-133092).

【0004】しかしこれらの指示薬は、希釈する前の有
機溶剤が高濃度の時は比較的安定であるのに対し、使用
濃度に希釈した場合には、保存安定性は十分でなく、経
日で発色剤が析出する、感度が低下する、更には、ペル
オキシダーゼ等の過酸化物分解性物質の酸化反応を阻害
するため、ペルオキシダーゼの量に正しく比例した吸光
度が得られず、正確な値を測定することが困難である
等、問題となる点も多かった。
However, while these indicators are relatively stable when the organic solvent before dilution is at a high concentration, when they are diluted to the use concentration, they are not sufficiently stable in storage and cannot be stored with the passage of time. Accurate measurement is not possible because the color developing agent is deposited, the sensitivity is reduced, and the oxidation reaction of peroxide-decomposable substances such as peroxidase is inhibited, so that the absorbance proportional to the amount of peroxidase cannot be obtained. There were many problems such as difficulty in doing so.

【0005】一方、有機溶剤を含まない系での使用につ
いては、キレート剤或はβ−シクロデキストリン(β−
CD)による保存安定性の改良が試みられてきた(例え
ば、特開昭59−193354、特開昭62−5021
00、特開昭63−61953号公報)。
On the other hand, for use in a system containing no organic solvent, a chelating agent or β-cyclodextrin (β-
Attempts have been made to improve the storage stability by CD (for example, JP-A-59-193354 and JP-A-62-5021).
00, JP-A-63-61953).

【0006】[0006]

【発明が解決しようとする課題】 しかしながら、これら
の系でも、依然、経日での発色剤の析出が認められ、そ
の結果、感度の低下が見られ、かつ過酸化物分解性物
質、特にペルオキシダーゼに正比例した正確な値の測定
も未だ困難であった。 これらのことは、正確性を重要な
要素として考える酵素免疫測定等の分析手段において、
その有用性を著しく制限するものである。 本発明はベン
ジジン系発色剤を測定用指示薬として使用する際、調製
時の感度が高く、経日的に感度の低下が認められず、更
には過酸化物分解性物質の量に比例した正確な吸光度を
示す指示薬の提供を目的とするものである。
[Problems to be Solved by the Invention] However, these
In this system, precipitation of the color former was still observed over time.
As a result, a decrease in sensitivity was observed, and peroxide-decomposable substances
Accurate measurement of quality, especially in direct proportion to peroxidase
Was still difficult. These things are important for accuracy
In analysis means such as enzyme immunoassay that is considered as an element,
It significantly limits its usefulness. The invention is Ben
Prepared when using a dizine-based coloring agent as an indicator for measurement
The sensitivity is high and no decrease in sensitivity is observed with the passage of time.
The correct absorbance is proportional to the amount of peroxide-decomposable substance
The purpose is to provide an indicating agent.

【0007】[0007]

【課題を解決するための手段】本発明者らは上記問題点
を改善するため鋭意検討した結果、ベンジジン系発色剤
の安定剤として、特定の化合物を用いることにより、調
製時の感度が高く、かつ長期間感度の低下がなく、ま
た、過酸化物分解性物質の量に比例した正確な値を測定
できることを見いだし、本発明に到達した。すなわち本
発明は、下記<1>及び<2>により構成される。 <1>水性媒体中に過酸化物(A)及びベンジジン系発
色剤(B)を溶解させてなり、過酸化物分解性物質
(C)の測定を(A)と(C)との反応に伴う(B)の
発色により行うことができる指示薬において、更に、γ
−CDを含有することを特徴とする過酸化物分解性物質
測定用指示薬。 <2>過酸化物分解性物質(C)もしくは(C)で標識
された化合物を構成品として含む試薬キットにおいて、
少なくとも上記<1>記載の指示薬もしくはこの指示薬
の各成分を共に構成品とすることを特徴とする試薬キッ
ト。
Means for Solving the Problems As a result of intensive studies for improving the above-mentioned problems, the present inventors have found that the use of a specific compound as a stabilizer for a benzidine-based color former provides high sensitivity during preparation, Further, they have found that the sensitivity does not decrease for a long period of time, and that an accurate value proportional to the amount of the peroxide decomposable substance can be measured, and the present invention has been accomplished. That is, the present invention includes the following <1> and <2>. <1> A peroxide (A) and a benzidine-based color former (B) are dissolved in an aqueous medium, and the peroxide-decomposable substance (C) is measured by a reaction between (A) and (C). In the indicator which can be performed by the color development of (B),
An indicator for measuring a peroxide-decomposable substance, characterized by containing CD. <2> A reagent kit comprising a peroxide decomposable substance (C) or a compound labeled with (C) as a component,
A reagent kit comprising at least the indicator described in the above <1> or each component of the indicator together as a component.

【0008】本発明において、過酸化物(A)として
は、例えば、過酸化水素、無機過酸化物(過ホウ酸ナト
リウム、過ホウ酸カリウム等)、有機過酸化物(クメン
ペルオキシド、t−ブチルペルオキシド、ジイソプロピ
ルベンゼンペルオキシド、2,5−ジメチルヘキサン−
2,5−ペルオキシド等)が挙げられる。これらのうち
好ましいものは過酸化水素である。
In the present invention, examples of the peroxide (A) include hydrogen peroxide, inorganic peroxides (sodium perborate, potassium perborate, etc.), organic peroxides (cumene peroxide, t-butyl). Peroxide, diisopropylbenzene peroxide, 2,5-dimethylhexane-
2,5-peroxide and the like). Preferred among these is hydrogen peroxide.

【0009】本発明において、ベンジジン系発色剤
(B)としては、例えば、ベンジジン、核置換ベンジジ
ン、N,N’−置換ベンジジン、これらの塩酸塩などの
従来公知の各種ベンジジン系発色剤が挙げられる。
(B)の具体例としては、ベンジジン、ベンジジン・2
HCl、O−トリジン、O−トリジン・2HCl、O−
ジアニシジン、3,3’,5,5’−テトラ(低級アル
キル)ベンジジン、3,3’,5,5’−テトラ(低級
アルキル)ベンジジン・2HCl・2H2 O、2,7−
ジアミノフルオレンなどが挙げられる。ここで用いる用
語「低級アルキル」は炭素数1〜6のアルキル基(メチ
ル、エチル、n−プロピル及びイソプロピル、並びに種
々のブチル、ペンチル及びヘキシル異性体)を意味す
る。以上(B)として例示したものは2種以上併用して
もよい。これらのうち好ましいのは3,3’,5,5’
−テトラ(低級アルキル)ベンジジンで、特に好ましい
のは、3,3’,5,5’−テトラメチルベンジジンで
ある。これらのベンジジン系発色剤(B)の調製は、塩
の形のものはそのまま水性媒体中に添加することがで
き、塩の形でないものは少量の有機溶剤に溶解して水性
媒体中に添加し、性能に影響を与えない程度に溶剤を除
去してもよい。
In the present invention, a benzidine-based coloring agent
Examples of (B) include benzidine and nuclear-substituted benzidi.
And N, N'-substituted benzidines, their hydrochlorides, etc.
Conventionally known various benzidine-based color formers can be mentioned.
Specific examples of (B) include benzidine and benzidine.2.
HCl, O-Tolidine, O-Tolidine.2HCl, O-
Dianisidine, 3,3 ', 5,5'-tetra (lower alkane
Kill) benzidine, 3,3 ', 5,5'-tetra (lower)
Alkyl) benzidine ・ 2HCl ・ 2H2 O, 2, 7-
Examples thereof include diaminofluorene. For use here
The term "lower alkyl" refers to an alkyl group having 1 to 6 carbon atoms (meth
Ru, ethyl, n-propyl and isopropyl, and seeds
Butyl, pentyl and hexyl isomers)
It Two or more of the materials exemplified above as (B) are used in combination.
Good. Of these, preferred are 3,3 ', 5,5'
-Tetra (lower alkyl) benzidine, particularly preferred
Is 3,3 ', 5,5'-tetramethylbenzidine
is there. The preparation of these benzidine-based color-developing agents (B) is carried out using salt
It can be added to the aqueous medium as it is.
If it is not in salt form, it is dissolved in a small amount of organic solvent and is aqueous.
Add it to the medium and remove the solvent to the extent that it does not affect the performance.
You may leave.

【0010】本発明において、過酸化物分解性物質
(C)としては、ペルオキシダーゼ(西洋ワサビ、牛
乳、白血球等から抽出したペルオキシダーゼ)またはカ
タラーゼのような活性酵素、この酵素と同様の作用を現
すヘモグロビン、チトクロームC及びそれらの誘導体、
紫外線、有機及び無機金属塩等が挙げられる。これらの
うち好ましいのは、ペルオキシダーゼ、特に西洋ワサビ
から抽出したペルオキシダーゼである。
In the present invention, as the peroxide decomposing substance (C), an active enzyme such as peroxidase (peroxidase extracted from horseradish, milk, leukocytes, etc.) or catalase, and hemoglobin exhibiting the same action as this enzyme. , Cytochrome C and their derivatives,
Ultraviolet rays, organic and inorganic metal salts and the like can be mentioned. Of these, preferred are peroxidases, especially peroxidase extracted from horseradish.

【0011】本発明において、カチオン界面活性剤
(D)としては、アミン塩型、第4級アンモニウム塩型
等があり、好ましいのは第4級アンモニウム塩型であ
る。第4級アンモニウム塩型としては塩化ベンザルコニ
ウム、塩化ベンゼトニウム、塩化ステアリルジメチルベ
ンジルアンモニウム、塩化ミリスチルジメチルベンジル
アンモニウム、塩化メチルラウリルジメチルベンジルア
ンモニウム、塩化ジデシルジメチルアンモニウムなどが
挙げられる。これらのうち特に好ましいのは、塩化ベン
ザルコニウムである。
In the present invention, the cationic surfactant (D) includes amine salt type, quaternary ammonium salt type and the like, and quaternary ammonium salt type is preferable. Examples of the quaternary ammonium salt type include benzalkonium chloride, benzethonium chloride, stearyldimethylbenzylammonium chloride, myristyldimethylbenzylammonium chloride, methyllauryldimethylbenzylammonium chloride and didecyldimethylammonium chloride. Particularly preferred among these is benzalkonium chloride.

【0012】本発明の指示薬を構成する各成分の含有量
について説明する。本発明の指示薬中の過酸化物
(A)、ベンジジン系発色剤(B)、γ−CD及びカチ
オン系界面活性剤(D)の各濃度は、測定方法および発
色反応を進めるための条件によって最適濃度が設定され
なくてはならない。また、これら(A)、(B)、γ−
CDおよび(D)の相互の濃度のバランスも考慮すると
よい。これらの前提はあるが、本発明の指示薬中の各成
分の含有量のうち、(A)の含有量は通常0.005〜
5mg/ml、好ましくは0.05〜0.2mg/ml
である。(B)については、通常0.01〜5.0mg
/ml、好ましくは0.03〜1.0mg/mlであ
る。γ−CDについては通常0.1〜50mg/ml、
好ましくは0.5〜30mg/mlである。また、カチ
オン系界面活性剤(D)についても特に限定しないが通
常使用する濃度でよい。具体的には0.01〜50mg
/ml、好ましくは0.5〜10mg/mlである。
The content of each component constituting the indicator of the present invention will be described. The concentrations of the peroxide (A), the benzidine-based color-developing agent (B), γ-CD and the cationic surfactant (D) in the indicator of the present invention are optimal depending on the measuring method and the conditions for promoting the color-developing reaction. The concentration must be set. Moreover, these (A), (B), and γ-
The balance of the mutual concentrations of CD and (D) may also be considered. Although these are premised, the content of (A) is usually 0.005 to 5 in the content of each component in the indicator of the present invention.
5 mg / ml, preferably 0.05-0.2 mg / ml
Is. For (B), usually 0.01 to 5.0 mg
/ Ml, preferably 0.03 to 1.0 mg / ml. γ-CD is usually 0.1 to 50 mg / ml,
It is preferably 0.5 to 30 mg / ml. Further, the cationic surfactant (D) is not particularly limited, but may be a concentration usually used. Specifically 0.01 to 50 mg
/ Ml, preferably 0.5-10 mg / ml.

【0013】本発明の指示薬を用いた過酸化物分解性物
質(C)の測定は、酸性サイド(pH2.5〜6.5)
でおこなわれることが好ましく、特にpH3.0〜5.
5で測定すると安定で良好な感度が得られる。発色反応
の場として用いられる緩衝液は前記のpHを満足させる
ものであればどのような種類の緩衝液を用いることも可
能であるが、フタル酸水素カリウム/水酸化ナトリウム
緩衝液、クエン酸二ナトリウム/塩酸緩衝液、クエン酸
二水素カリウム/水酸化ナトリウム緩衝液、コハク酸/
四ホウ酸ナトリウム緩衝液、クエン酸水素カリウム/四
ホウ酸ナトリウム緩衝液、リン酸水素二ナトリウム/ク
エン酸緩衝液、酢酸ナトリウム/塩酸緩衝液、酢酸/酢
酸ナトリウム緩衝液などが挙げられる。この際、好まし
い緩衝液濃度は0.1〜100mM、特に1〜50mM
である。
The measurement of the peroxide decomposable substance (C) using the indicator of the present invention was carried out on the acidic side (pH 2.5 to 6.5).
It is preferable to carry out at pH 3.0 to 5.
When measured at 5, stable and good sensitivity can be obtained. As the buffer solution used as the place for the color development reaction, any kind of buffer solution can be used as long as it satisfies the above pH, but potassium hydrogen phthalate / sodium hydroxide buffer solution, citrate diacid solution can be used. Sodium / hydrochloric acid buffer, potassium dihydrogen citrate / sodium hydroxide buffer, succinic acid /
Examples thereof include sodium tetraborate buffer, potassium hydrogen citrate / sodium tetraborate buffer, disodium hydrogen phosphate / citrate buffer, sodium acetate / hydrochloric acid buffer, acetic acid / sodium acetate buffer. At this time, the preferred buffer concentration is 0.1 to 100 mM, particularly 1 to 50 mM.
Is.

【0014】 本発明の指示薬の調製方法としては、ベン
ジジン系発色剤(B)を直接添加してもよく、予め他の
溶剤等に(B)を高濃度に溶解させたものを添加し、溶
解後必要に応じて溶剤を除去してもよい。これらに上記
過酸化物(A)及び過酸化物分解性物質(C)を添加
し、本発明の指示薬を得るが、特にこれらに限定される
ものではない。
[0014] The method for preparing the indicator of the present invention includes
The dizine-based color-developing agent (B) may be added directly.
Add (B) dissolved in a high concentration to a solvent, etc.
After dissolution, the solvent may be removed if necessary. Above these
Add peroxide (A) and peroxide decomposable substance (C)
To obtain the indicator of the present invention, but is particularly limited to these
Not a thing.

【0015】 発色反応を行う際の温度は過酸化物分解性
物質(C)の反応に最も適した温度(ペルオキシダーゼ
などの酵素の場合、通常20〜50℃)で実施すること
が好ましい。
[0015] The temperature for the color reaction is peroxide decomposable
The most suitable temperature for the reaction of substance (C) (peroxidase
In the case of enzymes such as, it is usually carried out at 20-50 ° C)
Is preferred.

【0016】測定の対象となる過酸化物分解性物質
(C)は遊離の状態でも、(C)により免疫活性物質等
の結合性物質(例えば抗原、抗体、ハプテン、プロテイ
ンA、アビジン、ビオチン、核酸)が標識された状態で
もよく、この標識物質が更に他の物質と結合後の複合体
の状態であってもよい。
Even if the peroxide decomposing substance (C) to be measured is in a free state, the binding substance (eg, antigen, antibody, hapten, protein A, avidin, biotin, etc.) such as an immunoreactive substance can be obtained by (C). (Nucleic acid) may be in a labeled state, or the labeled substance may be in a complex state after binding with another substance.

【0017】本発明の試薬キットは、過酸化物分解性物
質(C)もしくは(C)で標識された化合物とともに、
少なくとも本発明の指示薬もしくは本発明の指示薬の各
成分を構成品とするものである。ここで言う化合物とし
ては、上記に例示したような免疫活性物質等の結合性物
質を用いることができる。
The reagent kit of the present invention comprises a peroxide-decomposable substance (C) or a compound labeled with (C),
At least the indicator of the present invention or each component of the indicator of the present invention is a component. As the compound referred to herein, a binding substance such as an immunoactive substance as exemplified above can be used.

【0018】本発明の指示薬は、感度が高く、長期保存
でき、またペルオキシダーゼ等の過酸化物分解性物質の
濃度に比例して正確に測定できることから、このように
本発明の試薬キットの構成品とすることができ、そうす
れば従来のように指示薬の各成分を使用の都度配合しな
くてもよい利点がある。また、本発明の指示薬の各成分
の状態で本発明のキットの構成品とすることもでき、使
用時の配合は必要であるが、それでも感度及び正確性が
向上するなどの利点がある。
Since the indicator of the present invention has high sensitivity, can be stored for a long period of time, and can be accurately measured in proportion to the concentration of a peroxide decomposing substance such as peroxidase, it is thus a component of the reagent kit of the present invention. Therefore, there is an advantage that each component of the indicator does not have to be compounded each time as in the conventional case. Further, the components of the indicator of the present invention can be used as the components of the kit of the present invention, and it is necessary to mix them at the time of use, but there are advantages such as improvement in sensitivity and accuracy.

【0019】 以下、酵素免疫測定に利用される例とし
て、「酵素標識抗体」及び「本発明の指示薬」を構成品
として含むキットの例を挙げる。試験管、ガラスビー
ズ、プラスチックビーズ、マイクロパーティクル、ナイ
ロン膜、濾紙等の固相担体に抗体を予め結合させてお
く。これに試料を加え、測定対象物質である抗原と最初
の反応を行い、“抗体結合担体−抗原”の複合体を形成
する。未反応物を除去し、次に、先の複合体に親和性の
ある「酵素標識抗体」を加え、二番目の反応を行い、
“抗体結合担体−抗原−酵素標識抗体”なる複合体を形
成する。再度未反応物を除去し、最終的に担体に結合し
た酵素と本発明の指示薬と反応させ吸光度を測定する。
この吸光度は、試料中の測定対象物質の量に比例するの
で、既知濃度の標準物質を測定して作成した検量線から
試料中の測定対象物質量を求めることができる。
[0019] Below, as an example used for enzyme immunoassay
"Enzyme-labeled antibody" and "Indicator of the present invention"
Examples of kits including Test tube, glass bee
, Plastic beads, micro particles, ny
Antibodies are previously bound to a solid phase carrier such as a Ron membrane or filter paper.
Ku. A sample is added to this, and the first
Reaction to form the "antibody-binding carrier-antigen" complex
To do. Unreacted material is removed and then the affinity of the complex
Add a certain "enzyme-labeled antibody" and perform the second reaction,
Form a complex "antibody-binding carrier-antigen-enzyme-labeled antibody"
To achieve. Unreacted material is removed again, and finally bound to the carrier.
The enzyme is reacted with the indicator of the present invention and the absorbance is measured.
This absorbance is proportional to the amount of target substance in the sample
From a calibration curve created by measuring a standard substance of known concentration
The amount of the substance to be measured in the sample can be calculated.

【0020】本発明の試薬キットは、例えば酵素免疫反
応を利用し、α−フェトプロテイン(AFP)、癌胎児
性蛋白(CEA)、フェリチンなどの腫瘍マーカー、甲
状腺刺激ホルモン(TSH)、黄体形成ホルモン(L
H)、卵胞刺激ホルモン(FSH)、インシュリンなど
のホルモン、コルチゾール、トリヨードサイロニン(T
3)、サイロキシン(T4)などのハプテンホルモン、
ジゴキシン、テオフィリンなどの薬物、細菌、ウイルス
等の感染性物質、肝炎抗体、IgEなどの抗体の測定に
利用することができるが、必ずしもこれらの項目に限定
されるものではない。
The reagent kit of the present invention utilizes, for example, an enzyme immunoreaction, α-fetoprotein (AFP), carcinoembryonic protein (CEA), tumor markers such as ferritin, thyroid stimulating hormone (TSH), luteinizing hormone ( L
H), follicle-stimulating hormone (FSH), hormones such as insulin, cortisol, triiodothyronine (T
3), hapten hormones such as thyroxine (T4),
It can be used for measuring drugs such as digoxin and theophylline, infectious substances such as bacteria and viruses, hepatitis antibodies, antibodies such as IgE, but is not necessarily limited to these items.

【0021】 また、酵素免疫測定以外の検査試薬とし
て、「本発明の指示薬」を構成品として含むヘモグロビ
ン定量試薬キットの例を挙げる。 「本発明の指示薬」、
過酸化ストロンチウムを混合する。その後、ヘモグロビ
ンを含む試料を添加して一定時間反応する。吸光度をブ
ランクを対照として測定する。既知濃度のヘモグロビン
を測定して作成した検量線から、試料中のヘモグロビン
濃度を求める。
[0021] In addition, as a test reagent other than enzyme immunoassay
And hemoglobin containing the "indicator of the present invention" as a component
An example of a quantitative reagent kit is given below. "Indicator of the invention",
Mix strontium peroxide. Then hemoglobin
And a sample containing the same is reacted for a certain period of time. Absorbance
Rank is measured as a control. Known concentration of hemoglobin
From the calibration curve created by measuring
Calculate the concentration.

【0022】[0022]

【実施例】以下、実施例により本発明をさらに説明する
が本発明はこれに限定されるものではない。 また、本発
明の指示薬は必要に応じて、種々の添加剤(例えば、キ
レート剤、腐敗を防ぐ殺菌剤及び防腐剤、界面活性剤、
着色剤、消泡剤等)を更に添加することも可能である。
EXAMPLES The present invention will be further described below with reference to examples.
However, the present invention is not limited to this. Also,
The light indicator may have various additives (e.g.
Rate agents, bactericides and antiseptics to prevent spoilage, surfactants,
It is also possible to further add a colorant, an antifoaming agent, etc.).

【0023】実施例1 1) 指示薬[1]〜[3]の調製 20mMクエン酸緩衝液(pH4.0)10mlに、過
酸化水素が0.05mg/mlになる様に添加する。こ
の溶液に、γ−CDを最終濃度が1.0、4.0及び1
6.0mg/mlになるように添加し、更に、3,
3’,5,5’−テトラメチルベンジジン・2HCl
(以下TMB塩と略す)を5.0mg添加し、よく攪拌
することにより、それぞれ本発明の指示薬[1]〜
[3]を得た。
[0023]Example 1 1) Preparation of indicators [1] to [3]  Add 10 ml of 20 mM citrate buffer (pH 4.0) to
Add hydrogen oxide so that the amount of hydrogen oxide becomes 0.05 mg / ml. This
Γ-CD to a final concentration of 1.0, 4.0 and 1
It was added to 6.0 mg / ml, and
3 ', 5,5'-tetramethylbenzidine.2HCl
Add 5.0 mg (hereinafter abbreviated as TMB salt) and stir well
By doing so, the indicators of the present invention [1] to
Obtained [3].

【0024】2) 指示薬[比1]及び[比2]の調製 20mMクエン酸緩衝液(pH4.0)10mlに、過
酸化水素が0.05mg/mlになる様に添加する。こ
の溶液に、N−(2−ヒドロキシエチル)エチレンジア
ミン三酢酸鉄キレート(Fe-HEDTA)*1 及びβ−CDをそ
れぞれ5.0mg/mlになるように添加し、更に、T
MB塩を5.0mg添加し、よく攪拌することにより、
指示薬[比1]及び[比2]を得た。 *1 市販のHEDTA及びFeCl3・6H2Oの等モル量を水溶液中
で混合して鉄:キレートの1:1(モル:モル)Fe-HEDT
A溶液を調製
[0024]2) Preparation of indicators [ratio 1] and [ratio 2]  Add 10 ml of 20 mM citrate buffer (pH 4.0) to
Add hydrogen oxide so that the amount of hydrogen oxide becomes 0.05 mg / ml. This
Solution of N- (2-hydroxyethyl) ethylenedia
Mineral triacetate iron chelate (Fe-HEDTA) * 1 And β-CD
Add 5.0 mg / ml each, and add T
By adding 5.0 mg of MB salt and stirring well,
The indicators [ratio 1] and [ratio 2] were obtained.  * 1 Commercially availableHEDTAas well asFeCl3・ 6H2Equimolar amount of O in aqueous solution
Mixed with iron: chelate 1: 1 (mol: mol) Fe-HEDT
Prepare solution A

【0025】3) ペルオキシダーゼ溶液(POD溶液と
略す)の調製 1%牛血清アルブミン、0.85%NaCl、pH7.
2、0.02Mリン酸緩衝液(以下、PBSと略す)1
mlに、ペルオキシダーゼ(以下PODと略す)0.5
mgを溶解し、更に、PBSで500倍希釈して、PO
D溶液〈1〉(1μg/ml)を得た。また、POD溶
液〈1〉を、PBSを用いて2、4、8倍に希釈し、P
OD濃度が0.5、0.25、0.125μg/mlの
ものを調製し、それぞれPOD溶液〈2〉、〈3〉及び
〈4〉とした。
3) Peroxidase solution (with POD solution
Abbreviated) 1% bovine serum albumin, 0.85% NaCl, pH 7.
2, 0.02M phosphate buffer (hereinafter abbreviated as PBS) 1
0.5 ml peroxidase (hereinafter abbreviated as POD)
Dissolve mg and further dilute it 500 times with PBS,
D solution <1> (1 μg / ml) was obtained. In addition, the POD solution <1> is diluted 2, 4, or 8 times with PBS to obtain P
OD concentrations of 0.5, 0.25 and 0.125 μg / ml were prepared and used as POD solutions <2>, <3> and <4>, respectively.

【0026】4) 指示薬の感度試験 指示薬[1]〜[3]、[比1]及び[比2]各300
μlに、POD溶液〈1〉を50μl添加し、37℃、
15分反応させた。その後、分光光度計を用いて、65
0nmにおける吸光度を、POD溶液の代わりに水を添
加して反応させた液を対照に測定した。更に、4℃、2
5℃に1、3、6ヶ月保存した同様の指示薬について
も、それぞれPOD溶液〈1〉を反応させ、同様に吸光
度を測定した。結果を下記表1に示す。表1の結果から
明らかなように、本発明の指示薬[1]〜[3]は、指
示薬[比1]及び[比2]に比べて、調製時及び経日で
の感度の低下は著しく少ない。
4) Sensitivity test of indicators [1] to [3], [ratio 1] and [ratio 2] 300 each
Add 50 μl of POD solution <1> to μl,
It was reacted for 15 minutes. Then, using a spectrophotometer,
The absorbance at 0 nm was measured using a solution prepared by reacting with water instead of the POD solution as a control. 4 ° C, 2
With respect to the same indicator stored at 5 ° C. for 1, 3 and 6 months, the POD solution <1> was reacted and the absorbance was measured in the same manner. The results are shown in Table 1 below. As is clear from the results shown in Table 1, the indicators [1] to [3] of the present invention show significantly less decrease in sensitivity at the time of preparation and over time than the indicators [ratio 1] and [ratio 2]. .

【0027】[0027]

【表1】 [Table 1]

【0028】5) 希釈直線性試験 指示薬[2]、[比1]及び[比2]各300μlに、
POD溶液〈1〉、〈2〉、〈3〉及び〈4〉の各50
μlを添加し、37℃、15分反応させ、実施例1の4)
の感度試験に準じて各POD溶液の吸光度を測定した。
その結果を下記表2及び図1に示す。図1は、横軸にP
OD濃度、縦軸に650nmの吸光度をとり、POD濃
度と吸光度の関係を示したグラフである。指示薬[比
1]及び[比2]に比べ指示薬[2]は全領域のPOD
濃度においても直線性があり、正確な測定が可能である
ことを示している。
5) Dilution linearity test indicator [2], [ratio 1] and [ratio 2] 300 μl each,
POD solutions <1>, <2>, <3> and <4> 50 each
μl was added, and the mixture was reacted at 37 ° C. for 15 minutes, 4) of Example 1.
The absorbance of each POD solution was measured according to the sensitivity test of 1.
The results are shown in Table 2 below and FIG. In Figure 1, the horizontal axis is P
6 is a graph showing the relationship between POD concentration and absorbance by taking the OD concentration and the absorbance at 650 nm on the vertical axis. Compared to the indicators [ratio 1] and [ratio 2], the indicator [2] is the POD in the entire area
There is linearity in the concentration, indicating that accurate measurement is possible.

【0029】[0029]

【表2】 [Table 2]

【0030】実施例2 1) 指示薬[4]の調製 20mMクエン酸緩衝液(pH4.0)10mlに、過
酸化水素が0.05mg/mlになる様に添加する。こ
の溶液に、塩化ベンザルコニウム及びγ−CDをそれぞ
れ最終濃度が5.0mg/ml及び4.0mg/mlに
なるように添加する。更に、TMB塩を5.0mg添加
し、よく攪拌することにより、本発明の指示薬[4]を
得た。
Example 2 1) Preparation of indicator [4] Hydrogen peroxide was added to 10 ml of 20 mM citrate buffer (pH 4.0) so that the concentration would be 0.05 mg / ml. To this solution, benzalkonium chloride and γ-CD are added to final concentrations of 5.0 mg / ml and 4.0 mg / ml, respectively. Further, 5.0 mg of TMB salt was added and stirred well to obtain the indicator [4] of the present invention.

【0031】2) 指示薬[比3]及び[比4]の調製 γ−CDの代わりにFe-HEDTA及びβ−CDを添加する以
外は指示薬[4]と同様の調製方法で、指示薬[比3]
及び[比4]を得た。
2) Preparation of indicators [ratio 3] and [ratio 4] The indicator [ratio 3] was prepared in the same manner as the indicator [4] except that Fe-HEDTA and β-CD were added instead of γ-CD. ]
And [ratio 4] were obtained.

【0032】3) 指示薬の感度試験 指示薬[1]〜[3]、[比1]及び[比2]の代わり
に指示薬[4]、[比3]及び[比4]を用いる以外は
実施例1の4)と同様の方法で吸光度を測定した。結果を
下記表3に示す。表3の結果から明らかなように、本発
明の指示薬[4]は、指示薬[比3]及び[比4]に比
べて、調製時及び経日での感度の低下は著しく少ない。
3) Sensitivity test of indicator Example except that indicator [4], [ratio 3] and [ratio 4] are used instead of indicator [1] to [3], [ratio 1] and [ratio 2]. The absorbance was measured by the same method as in 1) 4). The results are shown in Table 3 below. As is clear from the results of Table 3, the indicator [4] of the present invention shows a markedly smaller decrease in sensitivity at the time of preparation and over time, as compared with the indicators [ratio 3] and [ratio 4].

【0033】[0033]

【表3】 [Table 3]

【0034】4) 希釈直線性試験 指示薬[1]〜[3]及び[比1]の代わりに指示薬
[4]、[比3]及び[比4]を用いる以外は実施例1
の5)と同様の方法で吸光度を測定した。その結果を表4
及び図2に示す。図2は、横軸にPOD濃度、縦軸に6
50nmの吸光度をとり、POD濃度と感度の関係を示
したグラフである。指示薬[比3]及び[比4]に比べ
指示薬[4]は全領域においても直線性があり正確な測
定が可能であることを示している。
4) Dilution linearity test Example 1 except that the indicators [4], [ratio 3] and [ratio 4] were used instead of the indicators [1] to [3] and [ratio 1].
The absorbance was measured by the same method as 5) above. The results are shown in Table 4.
And shown in FIG. In FIG. 2, the horizontal axis represents POD concentration and the vertical axis represents 6
It is the graph which took the light absorbency of 50 nm, and showed the relationship between POD concentration and sensitivity. Compared to the indicators [ratio 3] and [ratio 4], the indicator [4] has linearity even in the entire region, which indicates that accurate measurement is possible.

【0035】[0035]

【表4】 [Table 4]

【0036】[0036]

【発明の効果】【The invention's effect】

(1)感度の向上 本発明の指示薬は、使用するペルオキシダーゼ濃度領域
において、調製時の感度が高い。そのため、ペルオキシ
ダーゼの含有量が極めて少ない領域での測定でも有意差
が明確に判別される。このことは高感度が要求される検
査試薬には大変適している。 (2)保存安定性の向上 本発明の指示薬は、保存安定性が良好なので、試薬キッ
トの構成品とすることができる。従来の指示薬は、感度
が経日的に低下するため、使用直前に調製しなければな
らない等の問題があったのを解決するものである。ま
た、経日における発色剤の析出についても、結晶の析出
は起こらず、長期間に亙って安定な試薬の供給が可能で
ある。 (3)正確性の向上 本発明の指示薬は、ペルオキシダーゼ等の過酸化物分解
性物質の高濃度域或は低濃度域においても、過酸化物分
解性物質の量に正しく比例することから、極めて正確に
測定できるという利点がある。即ち、従来の指示薬で見
られた様な、発色反応を阻害することによる低値領域で
の感度低下が起こらず、その結果測定誤差が生じない。
このことは厳しい性能が要求される検査試薬にとって大
変好ましいものである。 (4)キャリーオーバーの防止 本発明の指示薬は、特にカチオン系界面活性剤の添加
で、キャリーオーバー(フローセル等の測定機器で感度
の高い試料を測定をした場合、次の試料の測定値が実際
より高くなる)が防止できる。このことは大量の試料を
自動測定する場合等に大変有利である。 (5)防腐効果 カチオン系界面活性剤を含む本発明の指示薬は、その殺
菌作用により防腐される。
(1) Improvement of sensitivity The indicator of the present invention has high sensitivity during preparation in the concentration range of peroxidase used. Therefore, the significant difference can be clearly discriminated even in the measurement in the region where the content of peroxidase is extremely low. This is very suitable for a test reagent that requires high sensitivity. (2) Improvement of storage stability Since the indicator of the present invention has good storage stability, it can be used as a component of a reagent kit. The conventional indicator solves the problem that it has to be prepared immediately before use because its sensitivity decreases with time. Further, with respect to the deposition of the color-developing agent over time, the deposition of crystals does not occur, and it is possible to stably supply the reagent for a long period of time. (3) Improvement of accuracy Even when the indicator of the present invention is in a high concentration range or a low concentration range of a peroxide-decomposable substance such as peroxidase, it is extremely proportional to the amount of the peroxide-decomposable substance. It has the advantage that it can be measured accurately. That is, the sensitivity is not lowered in the low value region due to the inhibition of the color development reaction as seen with the conventional indicators, and as a result, the measurement error does not occur.
This is very preferable for test reagents that require strict performance. (4) Prevention of carryover The indicator of the present invention is a carryover (in particular, when a highly sensitive sample is measured with a measuring device such as a flow cell, the measured value of the next sample is actually added by adding a cationic surfactant. Higher) can be prevented. This is very advantageous when automatically measuring a large number of samples. (5) Antiseptic effect The indicator of the present invention containing a cationic surfactant is antiseptic by its bactericidal action.

【図面の簡単な説明】[Brief description of drawings]

【図1】 図1は、実施例1における指示薬[2]、
[比1]及び[比2]のPOD濃度と発色度の関係を示
したものである。
FIG. 1 shows an indicator [2] in Example 1,
2 shows the relationship between the POD density and the degree of color development of [ratio 1] and [ratio 2].

【図2】 図2は、実施例2における指示薬[4]、
[比3]及び[比4]のPOD濃度と発色度の関係を示
したものである。
FIG. 2 shows an indicator [4] in Example 2,
4 shows the relationship between the POD density and the degree of color development of [ratio 3] and [ratio 4].

─────────────────────────────────────────────────────
─────────────────────────────────────────────────── ───

【手続補正書】[Procedure amendment]

【提出日】平成5年11月10日[Submission date] November 10, 1993

【手続補正1】[Procedure Amendment 1]

【補正対象書類名】図面[Document name to be corrected] Drawing

【補正対象項目名】図1[Name of item to be corrected] Figure 1

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【図1】 [Figure 1]

【手続補正2】[Procedure Amendment 2]

【補正対象書類名】図面[Document name to be corrected] Drawing

【補正対象項目名】図2[Name of item to be corrected] Figure 2

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【図2】 [Fig. 2]

Claims (7)

【特許請求の範囲】[Claims] 【請求項1】 水性媒体中に過酸化物(A)及びベンジ
ジン系発色剤(B)を溶解させてなり、過酸化物分解性
物質(C)の測定を(A)と(C)との反応に伴う
(B)の発色により行うことができる指示薬において、
更に、γ−シクロデキストリン(γ−CD)を含有する
ことを特徴とする過酸化物分解性物質測定用指示薬。
1. A method in which a peroxide-decomposable substance (C) is prepared by dissolving a peroxide (A) and a benzidine-based color former (B) in an aqueous medium. In the indicator which can be performed by the color development of (B) accompanying the reaction,
Further, an indicator for measuring a peroxide decomposable substance, which contains γ-cyclodextrin (γ-CD).
【請求項2】 γ−CDの含有量が0.1〜50mg/
mlである請求項1記載の指示薬。
2. The content of γ-CD is 0.1 to 50 mg /
The indicator according to claim 1, which is ml.
【請求項3】 (B)が3,3’,5,5’−テトラメ
チルベンジジンである請求項1または2記載の指示薬。
3. The indicator according to claim 1, wherein (B) is 3,3 ′, 5,5′-tetramethylbenzidine.
【請求項4】 (B)の含有量が0.01〜5mg/m
lである請求項1〜3のいずれか記載の指示薬。
4. The content of (B) is 0.01 to 5 mg / m.
The indicator according to any one of claims 1 to 3, which is l.
【請求項5】 (C)がペルオキシダーゼである請求項
1〜4のいずれか記載の指示薬。
5. The indicator according to claim 1, wherein (C) is peroxidase.
【請求項6】 γ−CDと共に、更にカチオン系界面活
性剤(D)を含有する請求項1〜5のいずれか記載の指
示薬。
6. The indicator according to any one of claims 1 to 5, which further contains a cationic surfactant (D) together with γ-CD.
【請求項7】 過酸化物分解性物質(C)もしくは
(C)で標識された化合物を構成品として含む試薬キッ
トにおいて、少なくとも請求項1〜6のいずれか記載の
指示薬もしくはこの指示薬の各成分を共に構成品とする
ことを特徴とする試薬キット。
7. A reagent kit comprising a peroxide decomposable substance (C) or a compound labeled with (C) as a constituent, at least the indicator according to any one of claims 1 to 6 or each component of the indicator. A reagent kit, characterized in that both are components.
JP4143617A 1992-05-07 1992-05-07 Indicator and reagent kit for measuring peroxide-decomposable substances Expired - Fee Related JPH07121235B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4143617A JPH07121235B2 (en) 1992-05-07 1992-05-07 Indicator and reagent kit for measuring peroxide-decomposable substances

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4143617A JPH07121235B2 (en) 1992-05-07 1992-05-07 Indicator and reagent kit for measuring peroxide-decomposable substances

Publications (2)

Publication Number Publication Date
JPH06165696A true JPH06165696A (en) 1994-06-14
JPH07121235B2 JPH07121235B2 (en) 1995-12-25

Family

ID=15342915

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4143617A Expired - Fee Related JPH07121235B2 (en) 1992-05-07 1992-05-07 Indicator and reagent kit for measuring peroxide-decomposable substances

Country Status (1)

Country Link
JP (1) JPH07121235B2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804404A (en) * 1996-01-22 1998-09-08 Dako Corporation Stable substrate-chromogen solutions for enenzyme activity detection
JP2007093399A (en) * 2005-09-29 2007-04-12 Miura Co Ltd Composition for measuring concentration of residual chlorine
US8080423B2 (en) 2004-08-05 2011-12-20 Asahi Kasei Pharma Corporation Reagent containing protease reaction promoter and/or colorant stabilizer
US8268017B2 (en) 2007-02-22 2012-09-18 Asahi Kasei Pharma Corporation Method for stabilizing leuco-type colorant
JP2017222845A (en) * 2016-06-08 2017-12-21 東ソー株式会社 Surfactant-containing reagent

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59193354A (en) * 1983-03-28 1984-11-01 マイルス・インコーポレーテッド Composition for detecting peroxide active substance, test means and manufacture of said test means and method of detecting peroxide active substance
JPS6361953A (en) * 1986-09-03 1988-03-18 Eiken Kagaku Kk Test piece for detecting peroxide active material
JPH0310696A (en) * 1989-06-09 1991-01-18 Wako Pure Chem Ind Ltd Measurement of body fluid component

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59193354A (en) * 1983-03-28 1984-11-01 マイルス・インコーポレーテッド Composition for detecting peroxide active substance, test means and manufacture of said test means and method of detecting peroxide active substance
JPS6361953A (en) * 1986-09-03 1988-03-18 Eiken Kagaku Kk Test piece for detecting peroxide active material
JPH0310696A (en) * 1989-06-09 1991-01-18 Wako Pure Chem Ind Ltd Measurement of body fluid component

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804404A (en) * 1996-01-22 1998-09-08 Dako Corporation Stable substrate-chromogen solutions for enenzyme activity detection
US8080423B2 (en) 2004-08-05 2011-12-20 Asahi Kasei Pharma Corporation Reagent containing protease reaction promoter and/or colorant stabilizer
JP2007093399A (en) * 2005-09-29 2007-04-12 Miura Co Ltd Composition for measuring concentration of residual chlorine
US8268017B2 (en) 2007-02-22 2012-09-18 Asahi Kasei Pharma Corporation Method for stabilizing leuco-type colorant
JP2017222845A (en) * 2016-06-08 2017-12-21 東ソー株式会社 Surfactant-containing reagent

Also Published As

Publication number Publication date
JPH07121235B2 (en) 1995-12-25

Similar Documents

Publication Publication Date Title
US4503143A (en) Enzyme immunoassay with two-part solution of tetramethylbenzidine as chromogen
BRPI1008760B1 (en) assay method and kit for one analyte in one sample and system for performing the assay method
CN101512342B (en) For the stabilizer and capture ligands of the measure for measuring analyte concentration
EP0321487A1 (en) Enhanced luminescent assay.
EP0235970A1 (en) Luminescent analyses with enhanced storage stability
US4452903A (en) Assay method and reagent kit means for lipid-containing body fluid
JPH06165696A (en) Indicator for measuring peroxide decomposing substance and reagent kit
HUT69994A (en) Method for the determination of the amount of a ligand in a biological fluid and kit for carrying out such a method
JPH0667960B2 (en) Method for separating analyte bound to binding protein and sample preparation reagent for measuring vitamin B12 in serum
EP0693552B1 (en) Analytical element, composition and method using modified apo-horseradish peroxidase
AU602864B2 (en) Method for measuring free ligands in biological fluids, and assay for measuring same
US5342788A (en) Method and standard solution for the determination of thyroxine (T4) or triiodothyronine (T3)
EP0152847A1 (en) Stabilized enzyme conjugate composition
JP2535290B2 (en) Indicator for measuring peroxide-decomposable substances
JPH0889291A (en) Indicator for measuring peroxide decomposing substance and reagent kit
AU630376B2 (en) Method for assaying immunologically active substance and reagent therefor
JPH0762679B2 (en) Indicator and reagent kit for measuring peroxide-decomposable substances
JP3711544B2 (en) Chemiluminescence measuring reagent
JPH05227995A (en) Indicator and reagent kit for determination of peroxide-decomposing substance
JPH0622794A (en) Indicator for measuring peroxide-decomposable substance and reagent kid
EP0210863A1 (en) Immunoassay
JP2542787B2 (en) Method for measuring thyroxine (T4) or triiodothyronine (T3) and standard solution therefor
JPH11512281A (en) Use of vanadium bromoperoxidase as a signal-generating enzyme for chemiluminescent systems, test kits and analytical methods
JPH0638757B2 (en) Peroxidase or H ▲ lower 2 ▼ O ▲ lower 2 ▼ measuring method
JPH08313525A (en) Composition for measuring enzyme immunity and its preparation

Legal Events

Date Code Title Description
FPAY Renewal fee payment

Free format text: PAYMENT UNTIL: 20071225

Year of fee payment: 12

FPAY Renewal fee payment

Free format text: PAYMENT UNTIL: 20081225

Year of fee payment: 13

FPAY Renewal fee payment

Year of fee payment: 14

Free format text: PAYMENT UNTIL: 20091225

LAPS Cancellation because of no payment of annual fees